CNBC September 12, 2024
Key Points
– Eli Lilly said it will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer’s drug and highly popular weight loss and diabetes treatments, among other medicines, in Ireland.
– The pharmaceutical giant said it is spending $1 billion to expand an existing site in Limerick, Ireland, to increase the production of certain active ingredients, including those used in its Alzheimer’s treatment Kisunla.
– The company also announced a new $800 million facility expansion in Kinsale, Ireland, which began manufacturing in 2023 to help meet demand for Eli Lilly’s diabetes and weight loss drugs.
Eli Lilly on Thursday said it will invest $1.8 billion to boost manufacturing for its newly approved Alzheimer’s drug and highly...
Today's Sponsors
Today's Sponsor